Background: Colangiolocellular carcinoma (CoCC) is a rare type of primary malignant liver tumor.
INTRODUCTION
Cholangiolocellular carcinoma (CoCC) is a rare type of primary malignant liver tumor, which was first reported by Steiner and Higginson in 1959 (1) . The incidence of CoCCs was reported to be 0.56% in patients with resected primary malignant liver tumors (2) . The tumor is thought to be derived from hepatic stem cells, which exist in the canals of Hering (2) (3) (4) (5) (6) (7) (8) (9) . CoCCs have been previously classified as a type of intrahepatic cholangiocarcinoma (10, 11) .
Currently, on the basis that combined hepatocellular-cholangiocarcinomas are derived from hepatic progenitor and/or stem cells (12) We conducted a retrospective analysis of the currently published CoCC cases, to determine their clinicopathological features and the potential surgical outcomes, including survival rates, for patients with this uncommon tumor.
METHODS

Eligibility criteria
The reporting of this systematic review was performed according to the Preferred Reporting
Items for Systematic Reviews and Meta-analyses (PRISMA) statement (16) . Both English and Japanese observational studies and articles were eligible for inclusion. There were no limitations with regards to the date of publication of the included studies. Only articles for which the full-text versions could be retrieved were included. For a study to be suitable for the qualitative synthesis, it had to contain information on the patient's surgical treatment for
CoCC. In addition, the study had to describe a defined follow-up period after the primary surgery, in which there had to be an assessment of the patient's outcome after the surgery. Any study, which did not meet the above-mentioned requirements, was not eligible for inclusion.
Literature search
A literature search was performed using the 
Study analysis
Survival rates were generated using the KaplanMeier method and compared by using the log-rank (Fig. 1d) . Immunohistochemically, the epithelial membrane antigen (EMA) was found to be strongly expressed in the membranous areas of the tubules. These findings are compatible with those obtained from other CoCC patients (Fig. 1e) .
Literature review
We identified 23 articles in PubMed and 32 articles from other sources (Fig. 2 ) that contained suitable data for our study. Ultimately, 55 articles were Table   1 ). The published diagnoses for all of the patients were true indications for surgical resection.
Clinicolpathological features of CoCCs
The clinicopathological characteristics of the examined CoCC cases are presented in Supplemental Cancer
Survival outcomes and recurrence patterns in patients with CoCCs
Survival outcome data was available for only 75
CoCC cases, including the patients from our hospital.
The mean follow-up term after curative surgery was 25.6 months (range, 0 to 140). Overall, the 1-, 3-, and (Fig. 3b) . The major sites of recurrence were the remnant liver (19 patients), lung (5 patients), bone (4 patients), and lymph node (2 patients). Among patients who experienced recurrence, the median time from surgery to recurrence was 13.0 months.
Subgroup analysis
By comparing the survival rates between the various subgroup identified by each predictive factor, the following factors were found to be significantly (Table 1) .
DISCUSSION
We conducted a retrospective analysis of 75 CoCC cases, with a focus on the clinicopathological features and surgical outcomes . This is the 
